Trial intelligence / Profile preview

Artemisia annua pollen drop preparation for allergic rhinitis

CTR20150073Phase 2Completed

Sponsor
Wolwo Biotech
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of artemisia annua in allergic rhinitis (AR), sponsored by Wolwo Biotech. Started Feb 2015; status: completed.

02

Drugs

artemisia annua
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on CTR20150073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call